Sign up to see all 5.
Sign up to see all 3.
No insider has filed a notice of proposed sale (Form 144) for Processa Pharmaceuticals Inc in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
CC
Connective Capital Management, LLC
|
85.3K | 3.05% | +14.5K (+20.6%) | Q1 '26 | 0.1% | |
|
Shares held by quarter
Peak holding85.3K (Q2'26)
Change over 8 quarters+85.3K
Share of the company3.050%
|
||||||
|
SC
Stonepine Capital Management, LLC
|
55.0K | 1.97% | Unchanged | Q3 '25 | 0.1% | |
|
Shares held by quarter
Peak holding1.0M (Q3'25)
Change over 8 quarters+55.0K
Share of the company1.970%
|
||||||
12 more super investors behind a free account
See every manager holding Processa Pharmaceuticals Inc, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
FE
Fidelity Concord Street Trust
|
$46.8K | 22.8K | 0.82% | 0.00% | August 31, 2026 |
|
VE
Vanguard Index Funds
|
$24.4K | 12.7K | 0.46% | 0.00% | June 30, 2026 |
2 more funds behind a free account
See every fund holding Processa Pharmaceuticals Inc and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
HE
HX Entertainment Ltd
5%+ holder
13D · 13.0%
|
305.6K | 10.94% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
NG
Ng George K
Insider
|
38.4K | 1.38% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company1.380%
|
||||||
9 more holders behind a free account
See every insider and 5%+ holder of Processa Pharmaceuticals Inc.
Sign up freeLoading...